Table 3.
Diagnosis | Morphology | IHC | Common Genetic Alterations |
---|---|---|---|
Neuroblastoma | Primitive cells; rosettes; neuropil; and ganglion cells | CD56, synaptophysin, and chromogranin | nMYC amplification; ATRK, ALK mutations; and chromosomal aberrations (1p, 17q, and 11q) |
Lymphoma | Variably sized hyperchromatic-blastoid cells with variable atypia; minimal cytoplasm | CD45, B/T-cell markers | Diverse |
Blastemic Wilms | Primitive, undifferentiated round-to-spindled cells | WT1 (N-terminus), CD56 | WT1, TP53 mutations; 11p15.5 deletion |
Small cell/neuroendocrine carcinoma | Small-medium round-oval cells; salt and pepper chromatin; indistinct nucleoli; molding; and apoptosis | Keratins CD56, synaptophysin, chromogranin, and TTF1 |
Diverse; TP53, PTEN mutations; RB1, 3p loss; and MYC amplification |
Metastatic Merkel cell carcinoma | Round-oval nuclei; high N/C-ratio; salt and pepper chromatin; indistinct nucleoli; molding; and apoptosis | Broad spectrum keratins; CK20 (dot-like), CD56, chromogranin, and synaptophysin | Diverse; depends on polyomavirus (PyV) status; PyV- tumors: Rb1, TP53 mutations |
Small cell mesothelioma | Solid nests; high N/C-ratio; well defined membrane; fine chromatin; and indistinct nucleoli | Calretinin, CK5/6, WT1 (N-terminus), and D2-40 | Diverse; P16 loss; BAP1 mutation; NF2 deletion; and ALK/EWSR1/FUS rearrangments |